Oric Pharmaceuticals Investor Relations Material
Latest events
Study Update
Oric Pharmaceuticals
Company Presentation
14 Aug, 2025
Q2 2025
12 Aug, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Oric Pharmaceuticals Inc
Access all reports
Oric Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies aimed at overcoming resistance in cancer. The company is dedicated to addressing one of the most significant challenges in oncology by targeting resistance mechanisms to improve the efficacy and durability of cancer treatments. Oric's research is concentrated on three primary resistance pathways: innate resistance, acquired resistance, and bypass resistance. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Oric Pharmaceuticals Inc
Company Presentation
Oric Pharmaceuticals Inc
Company Presentation
Oric Pharmaceuticals Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
ORIC
Country
🇺🇸 United States